We identified six novel biomarkers (PBK, KIF2C, NUF2, KIF20A, RAD51AP1, DEPDC1) that are related to the diagnosis and prognosis of ESCC. This evidence concerns the gene KIF2C and esophageal squamous cell carcinoma.